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a b s t r a c t
Syndromic and virological data are routinely collected by many countries and are often the only informa-
tion available in real time. The analysis of surveillance data poses many statistical challenges that have
not yet been addressed. For instance, the fraction of cases that seek healthcare and are thus detected
is often unknown. Here, we propose a general statistical framework that explicitly takes into account
the way the surveillance data are generated. Our approach couples a deterministic mathematical model
with a statistical description of the reporting process and is applied to surveillance data collected in
Italy during the 2009–2010 A/H1N1 inﬂuenza pandemic. We estimate that the reproduction number R
was initially into the range 1.2–1.4 and that case detection in children was signiﬁcantly higher than inpidemic modelling
arkov Chain Monte Carlo methods
ayesian inference
eporting process
adults. According to the best ﬁt models, we estimate that school-age children experienced the highest
infection rate overall. In terms of both estimated peak-incidence and overall attack rate, according to the
Susceptibility and Immunity models the 5–14 years age-class was about 5 times more infected than the
65+years old age-group and about twice more than the 15–64 years age-class. The multiplying factors
are doubled using the Baseline model. Overall, the estimated attack rate was about 16% according to the
ccordBaseline model and 30% a
ntroduction
The detection and control of existing, newly emerging or re-
merging infections in the human population often relies on the
nalysis of syndromic and virological surveillance data. Such data
re routinely collected in most developed and many develop-
ng countries, and are key for analysis of epidemics in real-time
o inform public health decision making. During the 2009–2010
/H1N1 inﬂuenza pandemic, syndromic and virological surveil-
ance data were routinely collected by most European countries
nd made available in real time. Since the emergence of the novel
1N1pdm inﬂuenza virus, many studies have been published on
he epidemiological characteristics of the disease and its transmis-
ion potential (Boëlle et al., 2009; Flahault et al., 2009; Fraser et al.,
009; Ghani et al., 2009; Cauchemez et al., 2009; Merler and Ajelli,
010), on the optimisation and assessment of the possible inter-
ention strategies (Lee et al., 2009; Yang et al., 2009; Baguelin et al.,
∗ Corresponding author at: MRC Centre for Outbreak Analysis and Modelling,
epartment of Infectious Disease Epidemiology, Imperial College London, Faculty
f Medicine, Norfolk Place, London W2 1PG, UK. Tel.: +44 020 7594 3229;
ax: +44 020 7594 8321.
E-mail address: i.dorigatti@imperial.ac.uk (I. Dorigatti).
755-4365/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
oi:10.1016/j.epidem.2011.11.001ing to the Susceptibility and Immunity models.
© 2011 Elsevier B.V. All rights reserved.
2010) and on the investigation of the natural history and character-
isation of infection at the individual level (Miller et al., 2010; Ross
et al., 2010). Moreover, a variety of different methods have been
proposed to estimate the epidemic infection rates on the basis of
serological (cross-sectional and cohort) studies (Miller et al., 2010;
Allwinnet al., 2010;Chenet al., 2010;Baguelinet al., 2011; Leeet al.,
2011) and syndromic and virological data (Baguelin et al., 2010;
Lee et al., 2011; Presanis et al., 2009; D’Ortenzio et al., 2010). These
latter studies rely on assumptions or estimates (mainly obtained
through health-seeking behavioural studies) of the reporting rates.
The analysis of syndromic and virological data poses many sta-
tistical challenges that have not yet been fully addressed. Only a
proportion of syndromic cases in the community seek healthcare
and are therefore eligible for detection by sentinel surveillance
systems. The size of the population that is monitored by primary-
care based surveillance also tends to change over time. Last, only
a fraction of syndromic cases who are detected by the surveil-
lance system have really been infected by the aetiological agent
of interest (e.g. H1N1pdm virus, in the past 2009–2010 inﬂuenza
pandemic), with the remainder of cases being due to other causes.
These problems are usually either ignored or corrected by scal-
ing the epidemic curve with multiplicative factors (Baguelin et al.,
2010), something which is expected to bias the variance of the esti-
mates. Here we present a general framework to tackle these issues
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nd analyse syndromic and virological data by taking stochastic-
ty in the surveillance system explicitly into account. We couple
deterministic model of transmission dynamics with a statisti-
al description of how the surveillance data is generated. To our
nowledge this is one of the ﬁrst studies that rigorously inte-
rates syndromic and virological data and the main novelty is in
he observational model, where we aim at modelling the stochas-
icity existing in the reporting process. Furthermore, the method
roposed in this study only requires standard syndromic and viro-
ogical surveillance data and is therefore potentially applicable to
broad range of countries for a variety of diseases.
Estimation of epidemiological parameters such as the reproduc-
ion number R, age-dependent reporting rates and susceptibility is
hen performed via Bayesian Markov Chain Monte-Carlo (MCMC)
ampling (Gilks et al., 1996). The approach is applied to surveillance
ata collected in Italyduring the2009–2010A/H1N1 inﬂuenzapan-
emic.
ata
nﬂuenza-like-illness and virology
For over ten years, inﬂuenza surveillance in Italy has been based
n a sentinel system called INFLUNET (Salmaso et al., 2000; SGNIV,
009). The number of practitioners involved in the surveillance
ystem during the 2009–2010 H1N1 pandemic inﬂuenza season
as on average 1094 (minimum 561, maximum 1165), covering
n average 1.4 million people (2.3% of the Italian population). Data
ollected by INFLUNETon theweekly size of themonitoredpatients
opulation and on the weekly number of observed inﬂuenza-like
llness (ILI) cases, aggregated by age groups (0–4 years, 5–14 years,
5–64 years and 65+years) are available online on the INFLUNET
ebsite (http://www.iss.it/iﬂu/).
Virological surveillance during the 2009 pandemic in Italy was
onducted by the Ministry of Health, which coordinated the col-
ection and testing of nasal swabs through hospitals, laboratories
perating within the national health service, sentinel GPs and
aediatricians. Weekly reports are available online on the Ital-
an Ministry of Health website under “sorveglianza virologica”
http://www.salute.gov.it/inﬂuenza/inﬂuenza.jsp).
We analyse ILI and virological data from week 38 of 2009 (cor-
esponding to mid September 2009, when the schools re-opened
fter the summer vacation) to week 7 of year 2010 (corresponding
o the end of February, when the epidemic had clearly died out).
ocial contact data
There is evidence that the number and structure of the con-
acts within an age-structured population signiﬁcantly vary over
ime, in particular between holiday/week-end days and working
ays (Hens et al., 2009, 2009). For this reason, using raw data from
he Italian arm of the POLYMOD survey (a diary-based survey of
aily contacts in eight European countries) (Mossong et al., 2008),
e compute the daily mean number of contacts among the con-
idered age classes during working days and holiday/week-end
ays. Finally, we use Italian demographic data for year 2008 which
an be found on the Italian National Statistical Institute website
http://www.istat.it/).
The methodology we adopted to compute the contact matrices
s very similar to those used in (Mossong et al., 2008). Starting from
he raw data of the POLYMOD survey (Mossong et al., 2008), we
omputed contactmatrices for the Italian population separately for
orking days and week-ends. As the Italian POLYMOD survey was
onducted between May 17th 2006 and June 1st 2006, a period
uring which no ofﬁcial holidays occurred, we were not able toics 4 (2012) 9–21
explicitly estimate contact rates in holidays, so instead used the
weekend estimates.
Since the age distribution of the survey population does not
match the Italian population age distribution, we standardise the
estimates. First, we calculate the average number of contacts per
participant in each age class with every other age class. We then
multiply these averages by the sizes of the corresponding par-
ticipant age classes in the Italian population, to get a matrix of
estimated total contacts between any two age classes in the Italian
population. Since the number contacts of class i with class j should
be the same as the number of contacts between j and i, we sym-
metrize the obtainedmatrix substituting each of the corresponding
off-diagonal pairs of elementswith their arithmeticmean.We then
divide each matrix element by the size of the participant age class
for that element, obtainingTablesSI-1andSI-2 (see theSupplemen-
tary Information), which represent the symmetric individual-level
contact matrices.
Model formulation
Transmission model
We use an age-structured deterministic transmission model,
where individualsmove frombeing susceptible, to exposed (butnot
yet infectious), to infectious before recovering (i.e. a SEIR model).
Five age classes are used (0–4, 5–14, 15–24, 25–64, 65+years).
The latent period (i.e. the duration of the exposed state) and the
infectious period are assumed to be Gamma distributed (this is
achieved by splitting each of the exposed and infectious states in
2 sub-compartments). The disaggregation of the 15–64 INFLUNET
age-class into 15–24 and 25–64 age-classes allows a better repre-
sentationof observedheterogeneity in contacts among the younger
age-groups which were particularly affected by the H1N1pdm
virus.
The model is deﬁned by the following differential equations
S˙i = −i(t)Si
˙E1i = i(t)Si − E1i
˙E2i = (E1i − E2i )
˙I1i = E2i − I1i
˙I2i = (I1i − I2i )
R˙i = I2i .
(1)
where i, j=1, . . ., 5 index the ﬁve age-classes 0–4, 5–14, 15–24,
25–64, 65+years. The rates of loss of latency  and infectiousness 
are assumed not to depend on the age class. The force of infection
i is given by
i(t) = pi
5∑
j=1
cij
(
h1
I1
j
(t)
Nj
+ h2
I2
j
(t)
Nj
)
(2)
wherei represents the susceptibility of age-class i, cij indicates the
mean number of contacts between an individual of age class i with
individuals of age class j, Nj represents the (constant in time) size
of age group j (with i, j=1, . . ., 5), p is for the probability of getting
infected upon a contact with an infectious individual and h1 and
h2 represent the infectivity of the two infectious stages I1 and I2,
respectively.
If we assume that at the beginning of the epidemic the
whole population is completely susceptible, the mean number of
pidemics 4 (2012) 9–21 11
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Fig. 1. Graphical representation of the populations taken into account and notationI. Dorigatti et al. / E
econdary infections generated by a single infective of age class j in
ge class i is given by
ij = pcji
∫ +∞
0
A()d i, j = 1, . . . ,5 (3)
here A() denotes the infectivity function at time  after infec-
ion. The entries given in (3) deﬁne the next generation matrix K
nd following (Diekmann and Heesterbeek, 2000) we deﬁne the
asic reproduction number R0 as the spectral radius s(K) of the next
eneration matrix
0 = s(K) = ps(C)
∫ +∞
0
A()d (4)
t turns out (see the SI for the whole computation) that the basic
eproduction number is given by
0 =
ps(C)(h1 + h2)

(5)
The effective reproduction number R is the expected number
f cases generated by a single infective when a fraction of the
opulation is protected against infection. If we assume that at the
eginning of the epidemic the whole population is susceptible and
hat susceptibility i varies across the age-classes i=1, . . ., 5, the
xpected number of cases generated by a ‘typical’ infective is given
y
ij = picji
∫ +∞
0
A()d i, j = 1, . . . ,5 (6)
nd the effective reproduction number R is
= s(K) = ps(M)(h1 + h2)

(7)
ith matrix M given by
ji = icji i, j = 1, . . . ,5 (8)
f we assume that at the early stages of the epidemic only a fraction
i(0)/N of the population is completely susceptible (Si(0) repre-
ents the number of fully susceptible individuals in age-class i at
he beginning of the epidemic and N=
∑
iNi is the total size of the
opulation) and the remaining part is fully immune, the effective
eproduction number R is still deﬁned by (7) with M given by
ji =
Si(0)
N
cji i, j = 1, . . . ,5 (9)
The reproductionnumberR is clearlyproportional top, theprob-
bility of infection given an infectious contact. We used R as a
arameter and calculated p as a function of R.
The mean generation time, deﬁned as the mean duration
etween time of infection of a secondary infectee and the time of
nfection of its primary infector (Wallinga and Lipsitch, 2007), is
iven by
g =
∫ +∞
0
A()d∫ +∞
0
A()d
= 2h1 + h1 + 2h2 + 2h2
(h1 + h2)
(10)
e assume a latency period (2/) of 1 day and ﬁx Tg =2.6 days,
ompatible with estimates obtained from 2009 H1N1 pandemic
Ghani et al., 2009; Cauchemez et al., 2009; Baguelin et al., 2010;
essler et al., 2009). We assigned the infectiousness parameters
alues by ﬁtting the infectiousness proﬁle (infectiousness as a
unction of time from infection) from the SEIR model to data on
ime-dependent viral shedding in experimental infection studies
Baccam et al., 2006), giving h1 =16.1 and h2 =9.6.
The model was coded in C and numerically solved using the
unge-Kutta algorithm with variable step size (Press et al., 2002).adopted in the work. The Italian population is considered constant over the whole
study period while the monitored patients population changes every week. Index i
denotes the age-class and t denotes the week.
The transmission model outputs Ct
i
, the number of A/H1N1 infec-
tions in week t and age-class i (i=1, . . ., 5) in the Italian population.
By scaling Ct
i
down to the size of the monitored population (i.e.
that covered by INFLUNET ILI sentinel surveillance), we obtain Z
t
i ,
the expected number of A/H1N1 infections generated within class
i during week t in the monitored population.
Statistical model
In what follows we adopt the notation graphically represented
in Fig. 1 for the purpose of clarity. Except for the variable Cit , which
represents the age-structured weekly number of A/H1N1 cases in
the Italian population, all the other variables are deﬁned at the
monitored population level. We assume sentinel GP reports are
all independent samples of the same population (thus GPs are
exchangeable and the absence of a GP report from a particular
week’s data is a random process). This almost underestimates true
variability (e.g. due to spatial heterogeneity), which is one reason
we explore models with overdispersion below.
It should be noted that no information on patient age was pro-
vided for the virological data, so we assume that t, the probability
that a person with ILI in week t is in fact infected with H1N1pdm
(and therefore would test positive), does not vary across the age-
groups.
We divide the presentation of the derivation of the likelihood
function L for the ILI and virological data in two parts. We ﬁrst
consider a case where we assume that the weekly number of
H1N1pdm infections in the monitored population in the ith age
class (represented by Zit) is subject to no sampling variability (or
dynamical stochasticity) and is equal to Z
i
t , the solution of the
deterministic transmission model. Then, we extend our model to
the situation when Zit can be over-dispersed. In this latter case
we assume that the distribution of Zit is Negative Binomial. The
Negative Binomial model has been chosen as an alternative to
the Poisson distribution to allow the sample variance to exceed
the sample mean, which is still ﬁxed at Z
i
t , the solution of the
deterministic transmissionmodel. The additional randomvariation
given by the over-dispersed model is meant to reﬂect the clus-
tered sampling, which occurs by monitoring only a sample of GPs,
whose patients will have speciﬁc spatial and social features. Fur-
thermore, assuming an over-dispersed model is a heuristic method
toallowforﬂuctuationsof thenumberof infected individualsdue to
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Zt∼NegBin r,
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t + r
(21)
where r is the dispersion. Decreasing values of r correspond to
increasing levels of overdispersion. The expected value is still Z
i
t ,
but the variance is Z
i
t
(
1 + Z
i
t
r
)
. Under this assumption, it can be
proved (see the SI) that2 I. Dorigatti et al. / E
ynamical stochasticity (i.e. away from the predictions of a deter-
inistic model).
o overdispersion
Since we lack information about the precise timing of collection
f the swabs, we assume that samples tested on week t had been
ollected from individuals who were symptomatic in week t−1.
iven t and the number of tested swabs Tt, the number of positive
wabs Pt follows the binomial distribution
(Pt |Tt,t) =
(
Tt
Pt
)
Ptt (1 − t)Tt−Pt (11)
et ILIit represent the number of ILI cases in the monitored popula-
ion of age-class i and week t, and Fit be the number of individuals
ith H1N1pdm infection in age-class i that report ILI symptoms in
eek t (Fig. 1). Hence, if i represents the probability that a person
nfected with H1N1pdm reports ILI symptoms, the distribution of
i
t is given by the Binomial model with parameters Z
i
t and i
(Fit |Z
i
t, i) =
(
Z
i
t
Fit
)

Fit
i
(1 − i)Z
i
t−Fit (12)
et NFit = ILIit − Fit represent the number of ILI cases (in the mon-
tored population) that are not infected with the A/H1N1 virus.
iven Fit , we model NF
i
t as the number of H1N1pdm-negative indi-
iduals one gets in a sequence of Bernoulli trials before obtaining
he Fitth positive individual. This is an approximation as in theory
otal ILIit can exceed the size of the corresponding monitored pop-
lation, and in addition it gives a higher variance to non-H1N1 ILI
han a Binomial model would. However, its use here signiﬁcantly
impliﬁes the later analysis.
Hence, given Fit > 0 and t, we assume that NF
i
t has a negative
inomial distribution with parameters Fit and 1−t
(NFit |Fit,1 − t) =
(
NFit + Fit − 1
Fit − 1
)

Fit
t (1 − t)NF
i
t (13)
ence
(ILIit |Fit, t) = P(NFit = ILIit − Fit |Fti , t)
nd the probability distribution of ILIit is explicitly given by
(ILIit |Fit, t) =
(
ILIit − 1
Fit − 1
)

Fit
t (1 − t)ILI
i
t−Fit (14)
f Fit = 0, then the whole ILIit set is uninfected with H1N1pdm, that
s
(ILIit |Fit, t) = (1 − t)ILI
i
t (15)
sing conditional probability and assumptions (13)–(15), the prob-
bility of the data given the model is hence given by
i
P(ILIit , Pt |Tt, Z
i
t , i) =
(
Tt
Pt
)
B(˛,ˇ)
⎛
⎝(1 − i)Zit B(Pt + ˛, ILIit + Tt − Pt + ˇ) + min∑
F(ILIit , Pt |Tt, Zt, i, t)
=
min(ILIit ,Z
i
t )∑
j=0
P(ILIit |Fit = j, t)P(Fit = j|Z
i
t, i)P(Pt |Tt,t) (16)ics 4 (2012) 9–21
Notice that, at this stage, the likelihood is a function of t. The
explicit estimation of t would be time consuming, challenging
(there is one such parameter for each week) and goes beyond the
scopes of this work.
For these reasons we assign a prior distribution P(t) to t and
integrate over t, thus obtaining
P(ILIit , Pt |Tt, Z
i
t, i)
=
min(ILIit ,Z
i
t )∑
j=0
∫ 1
0
P(ILIit |Fit = j, t)P(Fit = j|Z
i
t, i)P(Pt |Tt,t)P(t)dt(17)
Typically the integral over the t would not be analytically
tractable, meaning these parameters would need to be explicitly
estimated via MCMC along with the transmission parameters of
the model. However, by assuming a prior Beta distribution for t,
P(t) =
˛−1t (1 − t)ˇ−1
B(˛,ˇ)
(18)
where ˛ and ˇ are shape parameters, and then substituting (11),
(12), (14), (15) and (18) into (17), we can obtain (see the SI for
the complete computation) the following explicit evaluation of the
integral over t:
(
ILIit − 1
Fit − 1
)(
Z
i
t
F it
)

Fi
t
i
(1 − i)Z
i
t−Fit B(Fit + Pt + ˛, ILIit − Fit + Tt − Pt + ˇ)
⎞
⎠ (19)
Using 	 to denote the parameter vector, the Bayesian model is
deﬁned by:
P({ILIit}i,t , {Pt}t , 	|Tt) =
∏
t
∏
i
P(ILIit , Pt |Tt, Z
i
t(	), i)P(	) (20)
where P(	) is the prior distribution.
With overdispersion
Instead of taking Zit as being ﬁxed (and equal to Z
i
t), we can
account for variability in the reporting (or infection) process by
assuming that Zit is drawn from a negative binomial distribution
(Alexander et al., 2000; Lloyd-Smithet al., 2005; Lloyd-Smith, 2007;
Mathews et al., 2007; Cauchemez and Ferguson, 2008)
i
(
Z
i
t
)P(Fit |Z
i
t, i, r) =
(
Fit + r − 1
r − 1
)(
Z
i
ti
Z
i
ti + r
)Fit(
r
Z
i
ti + r
)r
(22)
pidem
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i(t) = ig(t) (25)
where g(38) =1, g(45) = a, g(52) =b, and g is linear in the intervals
before and after week 45. We estimate a, b and i with i=1, . . ., 4.
Table 1
Summary ofmodel parameter values (excluding contact rates). Abbreviations: est. =
estimated, Frac. = fraction. See main text for a description of how parameter values
were assigned or estimated.
Parameter Value

 Latency rate 2.0/day or est.
 Infectious rate 0.833/day
1 Susceptibility of age-class 0–4 years 0.98 or est.
2 Susceptibility of age-class 5–14 years 0.96 or est.
3 Susceptibility of age-class 15–24 years 0.85 or est.
4 Susceptibility of age-class 25–64 years 0.87 or est.
5 Susceptibility of age-class 65+years 0.73 or est.
S1(0)/N Frac. susceptible individuals 0–4 years
at baseline
0.98 or 1.0
S2(0)/N Frac. susceptible individuals 5–14
years at baseline
0.96 or 1.0
S3(0)/N Frac. susceptible individuals 15–24
years at baseline
0.85 or 1.0
S4(0)/N Frac. susceptible individuals 25–64
years at baseline
0.87 or 1.0
S5(0)/N Frac. susceptible individuals 65+years
at baseline
0.73 or 1.0
h1 Infectivity of the infectious stage I1 16.1
h2 Infectivity of the infectious stage I2 9.6
˛, ˇ Shape parameters of the Beta
distribution in Eq. (18)
1.0
R Effective reproduction number est.
I0 Number of H1N1 cases at week 31 est.
1 ILI reporting rate of H1N1 cases of
age-class 0–4 years
est.
2 ILI reporting rate of H1N1 cases of
age-class 5–24 years
est.
3 ILI reporting rate of H1N1 cases of
age-class 25–64 years
est.I. Dorigatti et al. / E
he probability of the data given the model is in this case given by
up to a normalising constant):
(ILIit , Pt |Tt, Z
i
t , i, r) =
(
Tt
Pt
)
B(˛,ˇ)
⎛
⎝(1 − qt
i
)Z
t
i B(Pt + ˛, ILIit + Tt − Pt + ˇ) +
min(ILIi
t
,Z
i
t )∑
Fi
t
=1
(
here for simplicity of notationwe set qit = Z
i
ti/(Z
i
ti + r). Expres-
ion (23) is been obtained substituting (11), (22), (14), (15) and (18)
nto formula
(ILIit , Pt |Tt, Z
i
t , i, r)
=
min(ILIi
t
,Z
i
t )∑
j=0
∫ 1
0
P(ILIit |Fit = j, t )P(Fit = j|Z
i
t , i, r)P(Pt |Tt,t )P(t )dt (24)
f we denote the parameter vector by 	, the Bayesian model is
eﬁned by (20) with (23) in place of (19).
odels variants and parameterisation
odel variants examined
From early on in the 2009 pandemic, it was noticed that the
hildren were particularly affected (Fraser et al., 2009; Ghani et al.,
009). There are two age-dependent parameters in our model
hich might explain this pattern: susceptibility (i.e. the probabil-
ty of getting infected given a contact with an infectious individual)
nd reporting rate (i.e. the probability that someone infected with
1N1pdm in the monitored population reports ILI symptoms).
ince the age distribution of cases effectively only provides infor-
ation on the product of susceptibility and reporting rates by age,
t is not possible to make inference on both parameters at the same
ime and one has to ﬁx one of the two and make inference on the
ther. We therefore explore 3 model variants in this paper:
Baseline model– here we assume that at the beginning of the epi-
demic the whole population is at least partially susceptible (i.e.
no fraction of the population is immune) and estimate the sus-
ceptibility of each age group prior to the pandemic (ﬁxing the
susceptibility of adults at 1.0, to avoid over-parameterisation)
and a reporting rate which is the same for all age groups (i.e.
1 = · · ·=5).
Susceptibility model – here we ﬁx values of the age-speciﬁc sus-
ceptibility parameters and ﬁt reporting rates (see below). We
assume that at the beginning of the epidemic the whole pop-
ulation is at least partially susceptible (i.e. no fraction of the
population is immune) and assign an age-speciﬁc susceptibility
to the different age-classes.
Immunity model – here we assume that at the beginning of the
epidemic a fraction of the population in each age-class is com-
pletely immunebut that the susceptible population is completely
and equally susceptible to H1N1pdm (1 = · · ·=5 =1.0). As for
the Susceptibility model, we ﬁt the reporting rate as an age-
dependent parameter.
Pre-existing immunity is modelled here (as in previous works
Baguelin et al., 2010; Mathews et al., 2007, 2010; Gojovic et al.,
009)) in two different ways: either by assuming that a proportion
f the population is partially protected against infection (Baseline
nd Susceptibility models) or by assuming that a fraction of the
opulation is completely immune (Immunitymodel).Whenassign-
ng either the average susceptibility of an age group (Susceptibility
odel) or the pre-pandemic proportion of an age group who were
mmune (Immunity model) we used pre-pandemic cross-sectionalics 4 (2012) 9–21 13
1
)(
Fit + r − 1
r − 1
)
(qit )
Fi
t (1 − qit )rB(Fit + Pt + ˛, ILIit − Fit + Tt − Pt + ˇ)
⎞
⎠ (23)
serological data from the UK (Miller et al., 2010). For the Immunity
model, the proportion of an age group assumed to be immune
is ﬁxed at the average of the proportion of baseline (pre-pandemic)
samples showing microneutralization titre at or above the cut-off
value of 1:40 and haemagglutination inhibition assay titre at or
above 1:32. For the Susceptibility model, the susceptibility of an
age group is ﬁxed at 1 minus the same average. The values of sus-
ceptibility used for the Susceptibility model and the proportion of
anagegroupassumed tobe fully susceptible in the Immunitymodel
are given in Table 1. We were forced to parameterise the models
using the UK serological data (Miller et al., 2010) since the sero-
logical study led in Italy by Rizzo et al., 2010 could not be applied,
due to an incompatible division of the population into age-classes
(1-55 years, 56-65 years, 65+ years).
For both the Immunity and Susceptibility models we deﬁne
Basic (same reporting rate for all age-groups (i.e. 1 = · · ·=5) and
constant over time), Age-Dependent Reporting (ADR – reporting
rate, i, ﬁtted separately for each age group, but assumed constant
over time) and Time-Varying Reporting (TVR – reporting rate ﬁt-
ted separately for each age group and can vary over time) model
variants. For the latter, we assume that the age-dependent report-
ing rate changes over time t (weeks) as given by a piecewise linear
function4 ILI reporting rate of H1N1 cases of
age-class 65+years
est.
a, b Parameters deﬁning the time
dependent reporting see Eq. (25)
est.
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e also examine the Basic and TVR variants for the Baseline model
with reporting rates always being the same for all age groups).
We ﬁt each of these model variants using the likelihood deﬁned
bove with and without over-dispersion.
nfection seeding and school holidays
We seed an initial number of A/H1N1 cases, I0, on week 31
mid August 2009) and ﬁt the model to the surveillance data in the
ime window between week 38 of year 2009 and week 7 of 2010.
he initial number of cases I0 is distributed among the age classes
roportionally to the vector (5%, 10%, 45%, 35%, 5%) which is com-
arable to the age distribution of reported cases over the summer
Rizzo et al., 2009). Model results are not sensitive to this choice of
ssignment.
In Italy schools re-opened after the summer vacation in 2009
n September 15th (week 38). Up until that time, we assign week-
nd contact rates to all those contact matrix elements that involve
chool-aged children (5–14 years). To reproduce Christmas holi-
ays (December23rd2009 to January7th2010)weassignweekend
ontacts to the whole population, reﬂecting the fact that most
dults are off work for much of the Christmas holiday, but not
ecessarily the summer holiday.
arameter estimation
In a Bayesian setting, we make inference on the parameters
hich are summarised in Table 1. Given the likelihood function
and chosen a (in our case uniform) prior distribution of the
arameters, the (target) posterior distribution is known up to a
ormalising constant. MCMC methods construct Markov chains
hose stationary distribution is the distribution of interest, when
t cannot be directly simulated. We implemented the classical
etropolis–Hastings algorithm (Gilks et al., 1996; Tierney, 1994;
alsh, 2004; O’Neill, 2002) and, starting from arbitrary initial val-
es in the parameter space, generated sequences of draws from the
nknown (target) probability distribution of the parameters. We
ssumeaﬂat prior distribution fort, thus setting the shapeparam-
ters ˛ and ˇ of equation (18) equal to 1.0. A log scale was used
or sampling as the parameters were all positive deﬁnite and were
xpected to potentially vary by orders of magnitude. We checked
onvergence by assigning different starting values in the parameter
pace (also far from the posterior mean) and by visual inspection
f the trace plots. The algorithm was iterated for 500,000 times
nd we ﬁxed a burn-in period of 100,000 steps. By tuning the vari-
nce of the proposal distribution, we adjusted the mixing of the
hains and attempted to reach a rate of acceptance (number of
ccepted moves/number of proposed points) as closest as possible
o the ‘golden’ acceptance rate for the Random Walk Metropolis
astings of 23% (Roberts et al., 1997). As expected, we found some
orrelations between certain parameters (for example, R0 and I0).
In addition to the log-likelihood, we use the Deviance Infor-
ation Criterion (DIC) for model comparison and selection, for
hich the preferred model is the one showing the lowest DIC
Spiegelhalter et al., 2002).
odel validation
For each model we draw 500 (sets of) parameters from the rel-
tive joint posterior distribution and with each set we numerically
olve the SEIR model in the Italian population. After rescaling theolution to the patient population (thus obtaining Z
i
t , the number
f patients infected by the A/H1N1 virus), in the models without
verdispersion we apply the Binomial model given in Eq. (12) and
raw 100 realisations of Fit , the number of ﬂu (H1N1pdm) casesnumber of reported H1N1-attributable ILI-cases (dashed), obtained by multiplying
the weekly ILI datum by the proportion of positive samples on the corresponding
week.
within the patients population. For the models with overdisper-
sion, we sample 100 realisations of Zit from Eq. (21) and for each
of these we draw Fit from Eq. (22). We hence obtain the simulated
H1N1 incidence curve to be compared with the observed data.
Results
The ILI incidence curve peaked on week 46 (mid November),
decreased over the next 6 weeks and then slowly increased again
during the ﬁrst weeks of 2010 (see Fig. 2). The H1N1-attributable
ILI-incidence curve (red dots) in Fig. 2 has been simply obtained
by multiplying the ILI incidence times the proportion of positive
swabs collected in that week, under the assumption that the sam-
ples tested on week t had been collected during week t−1.
We summarise the estimates (in termsofmeanand95% credible
interval) obtained for all the examined variants of the Base-
line model in Table 2. If we rescale the susceptibility estimates
reported in Table 2 to the values we estimated from serological
data (Miller et al., 2010) shown in Table 1, we ﬁnd that susceptibil-
ity drops with age more sharply than the serological data would
suggest (the rescaled mean estimates obtained in the basic no-
overdispersion variant are 1 =2.9, 2 =2.0, 3 =0.86, and 4 =0.6).
Table 3 summarises the estimates obtained for the Susceptibility
and Immunity models with over-dispersion for the ADR and TVR
variants. Tables SI-3, SI-4, and SI-5 in the Supplementary Informa-
tion report the estimates for the other model variants. Looking
across all these model variants, estimates of R are in the range
1.27–1.42. Models with overdispersion show slightly lower esti-
mates of R than those without overdispersion.
In Fig. 3 we plot the simulated H1N1 reported case incidence
curves (replicating the sample sizes of the data) obtained with the
TVR variants of the Baseline, Susceptibility and Immunity models
withoverdispersion, togetherwith theobservedH1N1-attributable
ILI incidence data. Comparable plots for other model variants are
given in Figures SI-1, SI-2, SI-3, SI-4 and SI-5. The box-plots are
generated as described in the ‘Model validation’ section.
As expected, themodelswith overdispersion showmuch higher
likelihoods (and lower DIC values) together with wider credi-
ble intervals around parameter and incidence estimates than the
I. Dorigatti et al. / Epidemics 4 (2012) 9–21 15
Table 2
Baseline model: mean and, in brackets, equal-tailed 95% credible interval of the marginal posterior distribution of the parameters for each speciﬁed model. Basic: reporting
rates constant in time and across the age groups. TVR: time-varying reporting, i.e. age-speciﬁc and time-dependent reporting rates as deﬁned by the piecewise linear function
given in Eq. (25).
Baseline model
No-overdispersion With-overdispersion
Basic TVR Basic TVR
DIC 2778.4 2614.5 1463.1 1455.7
Log-likelihood −1386.9 −1304.4 −728.2 −725.8
(−1384.4, −1391.1) (−1301.1, −1309.4) (−725.5, −732.7) (−722.6, −731.1)
R 1.417 1.379 1.321 1.315
(1.411, 1.424) (1.371, 1.389) (1.299, 1.343) (1.282, 1.350)
I0 2123 3174 7626 6249
(1794, 2502) (2586, 3803) (3982, 9850) (2081, 9747)
1 3.401 3.227 3.787 3.516
(3.296, 3.506) (3.131, 3.328) (3.009, 4.652) (2.844, 4.289)
2 2.308 2.174 2.040 1.999
(2.264, 2.349) (2.128, 2.220) (1.757, 2.347) (1.704, 2.355)
3 Fixed at 1 Fixed at 1 Fixed at 1 Fixed at 1
4 0.688 0.690 0.981 0.985
(0.646, 0.731) (0.649, 0.733) (0.725, 1.306) (0.737, 1.303)
1 = · · ·=4 0.178 0.217 0.175 0.311
(0.174, 0.183) (0.205, 0.237) (0.148, 0.206) (0.191, 0.556)
a – 0.952 – 0.603
– (0.852, 0.998) – (0.257, 0.955)
b – 0.220 – 0.300
.302)
r
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a– (0.150, 0
r – –
– –
espective no-overdispersion variants. While we discuss the limi-
ations of using a negative binomial model to describe unexplained
ariation later, we take the models with over-dispersion as being
referred over those without. However, to what extent can we dis-
inguish between the different mechanistic model variants? The
asic version of the Susceptibility and Immunity models clearly
t the data worse than the respective ADR and TVR variants (see
able SI-3 and Fig. SI-1). Comparing theADRversions of the Suscep-
ibility and Immunity models with the basic version of the Baseline
odel, all have identical numbers of ﬁtted parameters (7), but the
aseline model has the best ﬁt from a comparison of the mean
osterior log-likelihood or DIC values of each model. However,
able 3
DR and TVR with-overdispersion models (susceptibility and immunity variants): mean
ribution of the parameters for each speciﬁed model. ADR: age-dependent reporting, i.e.
ge-speciﬁc and time-dependent reporting rates as deﬁned by the piecewise linear funct
With-overdispersion
Susceptibility model
ADR TVR
DIC 1473.0 1453.0
Log-likelihood −733.0 −730.7
(−730.1, −737.9) (−727.4, −73
R 1.297 1.276
(1.275, 1.318) (1.236, 1.322)
I0 2431 3197
(1394, 4043) (639, 8227)
1 0.246 0.361
(0.197, 0.305) (0.167, 0.735)
2 0.165 0.228
(0.134, 0.204) (0.106, 0.464)
3 0.073 0.108
(0.059, 0.091) (0.050, 0.221)
4 0.069 0.105
(0.055, 0.088) (0.048, 0.217)
a – 0.971
– (0.284, 2.140)
b – 0.345
– (0.082, 0.888)
r 6.741 7.292
(4.280, 9.906) (4.600, 10.728– (0.094, 0.682)
8.092 8.776
(5.170, 11.794) (5.476, 13.070)
theposterior log-likelihoodcredible intervalsoverlap substantially.
The TVR model variants ﬁt 2 additional parameters, and achieve a
better ﬁt as measured by DIC, though the log-likelihood posterior
distribution overlaps with that of the non-time varying variants
for all three models. It is difﬁcult to distinguish the ﬁt quality
between the TVR variants of the Baseline, Susceptibility and Immu-
nity models (which each ﬁt 9 parameters), given the huge overlap
in the posterior distributions of the log likelihood and the very
limited difference in DIC values. The Baseline TVR model’s mean
log-likelihood is approximately 5 units higher than the other two
models, while the Susceptibility model has a marginally better DIC.
Given this, and that the Immunity TVR model is the best ﬁtting of
and, in brackets, equal-tailed 95% credible interval of the marginal posterior dis-
reporting rates constant in time and age-speciﬁc. TVR: time-varying reporting, i.e.
ion given in Eq. (25).
Immunity model
ADR TVR
1471.5 1455.2
−732.3 −730.4
6.0) (−729.4, −737.2) (−727.1, −735.6)
1.296 1.274
(1.274, 1.316) (1.234, 1.317)
2251 3150
(1287, 3702) (706, 8122)
0.267 0.365
(0.215, 0.332) (0.177, 0.708)
0.177 0.227
(0.143, 0.218) (0.109, 0.441)
0.082 0.112
(0.067, 0.101) (0.054, 0.217)
0.078 0.109
(0.062, 0.099) (0.052, 0.214)
– 1.032
– (0.336, 2.228)
– 0.387
– (0.101, 0.965)
6.925 7.403
) (4.400, 10.197) (4.660, 10.983)
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he models without overdispersion, we do not feel it is possible to
rmly choose one model over the other in terms of model ﬁt alone.
Biologically, the equally good ﬁt of all three models (and very
imilar estimates of R) means that the observed age distribution of
ases canbenearly equallywell explainedbyeither substantial age-
ependence in susceptibility to infection (Baseline model), or by
ubstantial age-dependence in reporting rates (Susceptibility and
mmunity models) – supporting our previous statement that age-
ependent reporting cannot be distinguished from age-dependent
rior immunity.
Table 4 therefore reports the peak-incidence (the highest
eekly incidence, occurring at the peak) and the cumulative attackate (ﬁnal size of the epidemic) for the TVR, with-overdispersion
ersions of all three models, while Fig. 4 shows the corresponding
nfection (as comparedwith reportedcase) incidenceover time. The
umulative attack rate has been computed over the whole study
TVR with-ove
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ig. 3. TVR with-overdispersion models (baseline, susceptibility and immunity variants
ncidences (per 1000) of symptomatic H1N1 cases (i.e. ILI and H1N1 cases) in the 0–4, 5–1
bserved data (i.e. the H1N1-attributable ILI incidence curve). TVR: time-varying reportin
inear function given in Eq. (25).ics 4 (2012) 9–21
period (from week 31 of 2009 to week 7 of 2010). We ﬁnd that
school-age children led and sustained the epidemic, followed by
younger children and young adults, while older adults were less
affected.
The absolute level of incidence varies markedly by model vari-
ant, however.At thecommunity level theestimatedpeak-incidence
is 27.4 (23.4, 33.1) per 1000 for the Baselinemodel, 42.1 (31.5, 54.0)
per 1000 for the Susceptibility model and of 37.5 (27.5, 47.2) per
1000 for the Immunity model. Corresponding cumulative infection
attack rates were 16.3% (14.3% , 18.9%), 26.7% (23.2% , 30.2%) and
23.9% (20.7% , 26.0%) respectively for those three models variants.
As expected, the Baseline model – which allows for much greater
variation in susceptibility to infection with age than the other two
– give much lower infection attack rates (and higher reporting
rates). There is some consistency in the relative magnitude of age-
speciﬁc attack rates obtained with the Susceptibility and Immunity
rdispersion
bility Immunity
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Fig. 3.
odels, with the the 0–4 and 5–14 years age-classes being respec-
ively about 3 and 5 times more affected than the 65+ years old
ge-group. The estimated attack rate in the 5–14 years age-class
btained with the Baseline model is consistent with the estimates
btained using the Susceptibility and Immunity models. Due to
ower attack rates in the 15–64 and 65+years old age-classes than
hose obtained with the Susceptibility and Immunity models, the
elative magnitude of age-speciﬁc attack rates obtained with the
aselinemodel is ampliﬁed,with the the5–14years age-class being
bout 11 times more affected than the 65+ years old age-group.
iscussion
In thisworkwepropose a general and rigorous statistical frame-
ork which explicitly takes into account the way surveillance data
re generated. Our methodology allows to ﬁt a transmission model
o virological and ILI data simultaneously, by taking into account
he uncertainty existing in the data.
able 4
stimated age-speciﬁc peak-incidence (peak-inc.) (per 1000) and cumulative attack rate
verdispersion models (baseline, susceptibility and immunity variants). The attack rate
ean and, in brackets, 5–95 percentile interval.
Estimates at the Italian population level
Baseline Suscepti
peak-inc. AR peak-inc
0–4 years 80.7 47.3 48.8
(68.6, 97.0) (40.5, 55.2) (36.4, 63
5–14 years 92.9 52.5 86.1
(76.8, 108.6) (47.9, 56.6) (66.8, 10
15–64 years 21.1 12.5 43.9
(16.7, 27.2) (9.8, 16.0) (32.8, 56
65+years 7.6 4.5 15.6
(5.7, 10.3) (3.4, 6.0) (11.3, 20
Overall 27.4 16.3 42.1
(23.4, 33.1) (14.3, 18.9) (31.5, 54ek week
inued )
Let us consider parameters t, the weekly probability that a
swab tests positive. In the absence of any ILI data, the maxi-
mum likelihood estimate of t is simply Pt/Tt, where Tt represents
the weekly number of individuals (showing ILI symptoms in the
monitored population) who are virologically tested and Pt is the
number who test positive for H1N1 infection (Fig. 1). The rela-
tively fewnumberof individualswhoarevirologically testedmeans
that estimates of t typically have considerable uncertainty. This
uncertainty needs to be taken into account when ILI data are avail-
able and we want to correctly estimate the parameters of interest
(i.e. transmission parameters and reporting rates). Rather than
just multiplying ILI incidence with our naive estimate of t =Pt/Tt
(Baguelin et al., 2010), we estimate here the likelihood of the
observed counts of positive samples and overall ILI simultaneously.
The introduction of a negative binomial distribution as a model
for variation in underlying infection incidence (Zt
i
) is a heuristic
mechanismfor allowing forover-dispersion in incidence countdata
(Mathews et al., 2007; Cauchemez and Ferguson, 2008). The esti-
mated values of the dispersion parameter r (1.7–13.1) are in the
(AR) (%) of H1N1 infections in the Italian population obtained with the TVR with-
is computed on the time period starting from week 31 of 2009 to week 7 of 2010.
bility Immunity
. AR peak-inc. AR
30.8 44.2 28.1
.3) (26.6, 35.2) (32.0, 56.1) (24.1, 31.9)
52.9 79.2 49.0
7.0) (47.5, 58.2) (60.4, 98.4) (43.6, 53.7)
27.8 38.7 24.7
.8) (24.0, 31.6) (28.1, 48.9) (21.3, 27.8)
9.9 13.7 8.7
.6) (8.3, 11.6) (9.8, 17.8) (7.4, 10.1)
26.7 37.5 23.9
.0) (23.2, 30.2) (27.5, 47.2) (20.7, 26.9)
1 pidem
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ange already used by other authors, but resulted in rather wide
redible intervals for theexpectednumberof infections inanygiven
eek (see for instance Fig. 3).
Overall, judging which model is preferred in this study is
hallenging. Clearly the models with overdispersion have much
Estimated incidence (per 1000) of H1N
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ig. 4. Estimated mean, 95%CI, maximum and minimum weekly incidences of H1N1 case
verall population obtained using the TVR, with-overdispersion model in its baseline, sus
core.ics 4 (2012) 9–21
lower DIC values, but at the cost of introducing dynamically
unconstrained levels of variation in the model. Comparing the
models with and without overdispersion clearly indicates that the
assumption that the epidemic process is deterministic and spa-
tially homogeneous across Italy is a poor one. But the assumption
1 cases in the Italian population
ility Immunity
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Fig. 4.
hat incidence is negatively binomially distributed is also crude,
nd almost certainly over-estimates the degree of variation (for
nstance, by not allowing for any temporal correlation in the noise
ntroduced). Reality almost certainly lies between the two. That
aid, the magnitude of difference in log likelihood and DIC mod-
ls between the models with and without overdispersion leads
s to focus on presenting results from models in the presence of
verdispersion.
Comparison of measures of model ﬁt does not allow us to
onvincingly choose between the Baseline, Susceptibility and
mmunity model variants with ﬁtted age-speciﬁc susceptibility or
eporting rates, however. Including time-varying reporting rates
mproves model ﬁt somewhat (though visually it is hard to see the
ifference on incidence plots, and the posterior log-likelihood dis-
ributions heavily overlapped with the models without TVR), but
ll three TVR models (with over-dispersion) had identical num-
ers of ﬁtted parameters, very similar DIC values, and overlapping
osterior log-likelihood distributions. In choosing between models
e therefore have to rely on biological plausibility and comparison
ith data collected in other countries.
We found that the estimates of the reproduction number R var-
ed depending on the model but all fell in the range 1.2–1.4, with
.3 being the value preferred by the best ﬁt model variants. These
stimates are consistent with those of (Ajelli et al., 2011) derived
rom the exponential growth phase of the ILI number of cases and
Poletti et al., 2011) on the same dataset. They also agree with
ecent estimates for the fall pandemic wave in Mexico (Chowell
t al., 2011; Pourbohloul et al., 2009), for the initial transmission in
ntario province (Canada) (Tuite et al., 2010) and with the lower
ound of the basic reproduction number estimates obtained from
he early spread of pandemic H1N1 in La Gloria (Mexico) (Fraser
t al., 2009) and in the United States (Yang et al., 2009).
The results obtained using the Baseline model conﬁrm a sub-
tantially lower susceptibility to H1N1 in adults compared with
hildren, with a larger difference than would have been expected
rom baseline (pre-pandemic) UK serological data (Miller et al.,
010). However, the equally well ﬁtting Susceptibility and Immu-
ity models explain the same trends equally by allowing reporting
ates to vary with age. It is likely both susceptibility and report-
ng rates were higher in children and lower in adults, but the
xact age-dependence of each is difﬁcult to resolve without addi-
ional data. Post-pandemic serology data now available from a
umber of countries (Hardelid et al., 2010; Wu et al., 2010; Xu
t al., 2011; Tandale et al., 2010) shows age-speciﬁc seroconver-
ion ratesmore compatiblewith estimates from theBaselinemodel
han from the other two models (which produce much higher
nfection attack rate estimates in adults), suggesting that variation
n susceptibility to infection with the H1N1pdm virus was more
xtreme than suggested from serological testing of pre-pandemic
amples.ek week
inued )
Our estimates of time-varying reporting rates suggest a declin-
ing reporting rate late in the pandemic, perhaps reﬂecting
decreased concern. Some model variants show an increase in
reporting rate close to the peak of the pandemic (Cauchemez and
Ferguson, 2008), perhaps reﬂecting greaterworry and awareness of
the pandemic in the general population when incidence was high
(Rubin et al., 2010). Studies to quantify changes inhealth-care seek-
ing behaviour over time would be desirable in future pandemics
(Rubin et al., 2010; Jones and Salathé, 2009).
Our analysiswouldbeneﬁt fromthe availability ofmoredetailed
information on the criteria adopted for the collection of the swabs.
For instance, information on the day of collection of the swab or,
alternatively, on the average delay between collection and test-
ing of the samples would give us more accurate data and hence
more accurate and reliable results. Delays in the laboratory con-
ﬁrmation of the swabs can potentially have biased our estimates.
Informationon the eventual changes occurred in the collectionpro-
cess during an epidemic are also essential, as these changes are
potentially another source of bias of the data. We assumed that the
swabs selected for testing were a random sample of all ILI cases
while in reality a sizeable proportion were collected outside the
normal virological surveillance system – presumably in hospitals
andGPs for clinical reasons, potentially biasing the results from this
surveillance source. Unfortunately, the available data do not allow
us to disaggregate swab results by source, which would be another
important information.
Finally, this type of study would clearly have beneﬁted from the
availability of age-speciﬁc virological data, ideally stratiﬁed accord-
ing to theage-classesusedby thesyndromic surveillance system(or
to a compatible age-stratiﬁcation). If age-speciﬁc virological data
had been available, we would have been able to distinguish bet-
ter between model variants and therefore produced more reliable
estimates of age-speciﬁc infection rates.
There are some minor systematic deviations between model
estimates and the data (for instance, the predicted incidence in the
ﬁrst fewﬁttedweeks of the epidemic are systematically lower than
the observed data in the 0–4 age-class and systematically higher
than the observed data in the 5–14 age-class). Clearly this aspect of
model ﬁt might be improved by increasing model complexity, for
instance by making the modelled proportion of ILI cases which test
positive for H1N1pdm inﬂuenza age-dependent. However, the cost
of increased model complexity is poorer parameter identiﬁability
(and greater computational requirements). Overall, we feel the rel-
atively simple model we used here gives an adequate description
of the trends seen in the surveillance data, and is at the limit of
acceptable complexity in terms of being able to be rigorously ﬁtted
to the available data.
The general modelling framework proposed in this work can be
rapidly applied to the analysis of other inﬂuenza surveillance data
(both pandemic and seasonal), provided that epidemiological and
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irological data are available. As such, the methodology developed
n this work is a potentially powerful tool for providing real-time
pidemiological estimates to public health ofﬁcials and policy-
akers.
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